The robotics startup, whose investors also include BD, wants to grow sales to $1 billion by 2027. CEO Adam Sachs contends legacy robot platforms are too costly and inefficient.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,